🔎 Trials Near Me

Beranda › PPOK › Louisiana › Shreveport

Uji klinis PPOK di Shreveport, LA

5 studi untuk PPOK mencari peserta di lokasi sekitar Shreveport (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Menerima pesertaFase 3
  • Research Site, Shreveport
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Menerima pesertaFase 3
  • Ochsner LSU Health Shreveport - Academic Medical Center- Site Number : 8400083, Shreveport
  • Care Access - Shreveport - Youree Drive- Site Number : 8400007, Shreveport
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07190222

STRIVE Post-Market Registry Study

Menerima pesertaStudi observasional
  • LSU Health Shreveport, Shreveport
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Menerima pesertaFase 3
  • GSK Investigational Site, Shreveport
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07177339

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Menerima pesertaFase 3
  • GSK Investigational Site, Shreveport
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT06961214

Uji klinis PPOK di kota lain

Studi lain di Shreveport

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.